Revolution Medicines, Inc. (RVMD) Operating cash flow 2018–2025
Revolution Medicines, Inc. (RVMD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$897.7MFY2025 · since FY2018: $1.2M → -$897.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$897.7M | -61.0% |
| FY2024 | -$557.4M | -59.0% |
| FY2023 | -$350.6M | -56.2% |
| FY2022 | -$224.4M | -52.5% |
| FY2021 | -$147.2M | -47.1% |
| FY2020 | -$100.1M | -101.7% |
| FY2019 | -$49.6M | -4190.4% |
| FY2018 | $1.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice